An audit of influenza and pneumococcal vaccination in rheumatology outpatients
<p>Abstract</p> <p>Background</p> <p>Influenza and pneumococcal vaccination are recommended for a number of clinical risk groups including patients treated with major immunosuppressant disease modifying anti-rheumatic drugs. Such immunisation is not only safe but immuno...
Main Authors: | Mitchell William S, Sowden Evin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-07-01
|
Series: | BMC Musculoskeletal Disorders |
Online Access: | http://www.biomedcentral.com/1471-2474/8/58 |
Similar Items
-
An audit of the use of hydroxychloroquine in rheumatology clinics
by: Worth, C, et al.
Published: (2018) -
Awareness of Influenza and Pneumococcal Vaccination in the Geriatric Age Group
by: Süheyla AYDOĞMUŞ, et al.
Published: (2010-12-01) -
Pure analgesics in a rheumatological outpatient clinic
by: T. Maio, et al.
Published: (2001-06-01) -
Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity
by: Sylvan Staffan PE, et al.
Published: (2008-04-01) -
Pneumococcal vaccination in rheumatic diseases: 10 years of application experience at the V.A. Nasonova Research Institute of Rheumatology
by: B. S. Belov, et al.
Published: (2022-07-01)